Hypertrophic Cardiomyopathy

Novel studies from around the world showing cutting-edge clinical use of cardiovascular magnetic resonance (CMR) will be presented at EuroCMR 2019, a meeting of the European Association of [...]

Critical Path Institute’s (C-Path) Data Collaboration Center (DCC) and the Friedreich’s Ataxia Research Alliance (FARA) today announced the launch of the Friedreich’s Ataxia [...]

One third of hypertrophic cardiomyopathy cases in Finland are caused by one of the four major mutations, a new study from the University of Eastern Finland and Kuopio University Hospital shows. [...]

Ultromics, the U.K. start-up behind the world’s first outcomes driven, AI-based, ultrasound diagnostic support tool for coronary artery disease (CAD), is currently supporting multiple ongoing [...]

When a young athlete suddenly dies of a heart attack, chances are high that they suffer from familial hypertrophic cardiomyopathy (HCM). Itis the most common genetic heart disease in the US and [...]

A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to new research in Journal of the American Heart Association, the Open Access [...]

Seattle Children’s today announced the opening of its newest regional clinic, Seattle Children’s North Clinic, which will provide convenient access to pediatric specialty care [...]

A new study by Professors Martti Juhola and Katriina Aalto-Setälä of the University of Tampere in Finland demonstrates that with the use of artificial intelligence and machine learning, it is [...]

Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies, according to new [...]

Scientists may now be able to use gene editing and stem cell technologies to predict whether carrying a specific gene variant increases a person’s risk of heart disease, according to a new study [...]